Cargando…

Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel Disease

Detalles Bibliográficos
Autor principal:	Kim, Seong-Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933403/ https://www.ncbi.nlm.nih.gov/pubmed/27377736 http://dx.doi.org/10.5009/gnl16272

Ejemplares similares

Serum Procalcitonin for Differentiating Bacterial Infection from Disease Flares in Patients with Autoimmune Diseases
por: Joo, Kowoon, et al.
Publicado: (2011)

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease
por: Chung, Sook Hee, et al.
Publicado: (2016)

The role of latanoprost in an inflammatory bowel disease flare
por: Paul, Sonali, et al.
Publicado: (2014)

Serum procalcitonin as a diagnostic tool of bacteremia
por: Gartzonika, C, et al.
Publicado: (2010)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections
por: Poirot-Seynaeve, Xavier, et al.
Publicado: (2023)

Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021)

Seasonal Variation in Months of Birth and Symptom Flares in Korean Patients with Inflammatory Bowel Disease
por: Jung, Yoon Suk, et al.
Publicado: (2013)

Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults
por: Sun, Yue, et al.
Publicado: (2019)

Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups
por: Kaddourah, Osama, et al.
Publicado: (2019)

Micronutrients Should Be Monitored in the Real Practice for Korean Inflammatory Bowel Disease Patients
por: Kim, Seong-Eun
Publicado: (2017)

Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies
por: Yang, Mina, et al.
Publicado: (2019)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare
por: Uemura, Risa, et al.
Publicado: (2016)

Can procalcitonin reflect the etiology of the bacteremia?
por: Chernevskaya, Ekaterina, et al.
Publicado: (2007)

Is It Inflammatory Bowel Disease Flare or Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19?
por: Krawiec, Paulina, et al.
Publicado: (2022)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Serum galectins as potential biomarkers of inflammatory bowel diseases
por: Yu, Tony B., et al.
Publicado: (2020)

Bacteremia affects the mortality of septic patients with high serum procalcitonin level in the ICU
por: Kamochi, M, et al.
Publicado: (2012)

Elevated Procalcitonin in Acute Pseudogout Flare: A Case Report
por: Vasishta, Shilpa, et al.
Publicado: (2019)

Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease
por: Burisch, Johan, et al.
Publicado: (2021)

Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Kessel, Christoph, et al.
Publicado: (2021)

Serum procalcitonin: Early detection of neonatal bacteremia and septicemia in a tertiary healthcare facility
por: Nnanna, Ibeh Isaiah, et al.
Publicado: (2011)

Application of Procalcitonin for the Rapid Diagnosis of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
por: Xie, Shuhua, et al.
Publicado: (2022)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
por: Kim, Eun Soo
Publicado: (2017)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Assessment of Medication Adherence and Pharmacist Intervention Are Important for the Care of Patients with Inflammatory Bowel Disease
por: Kim, Eun Sil, et al.
Publicado: (2022)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Flare-IBD: development and validation of a questionnaire based on patients’ messages on an internet forum for early detection of flare in inflammatory bowel disease: study protocol
por: Ricci, Laetitia, et al.
Publicado: (2020)

Procalcitonin as a biomarker of infectious diseases
por: Lee, Hyuck
Publicado: (2013)

Dietary role in the development and treatment of inflammatory bowel disease
por: Kim, Jae Young
Publicado: (2020)

Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease
por: Williams, Amanda D., et al.
Publicado: (2017)

Biomarkers of Inflammatory Bowel Disease
por: Fengming, Yi, et al.
Publicado: (2014)

Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
por: Eun, Chang Soo
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ajenc05s0qa7uf739gkla3sl24